| 000 | 01313 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514211845.0 | ||
| 264 | 0 | _c20041223 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a1095-9203 | ||
| 024 | 7 |
_a10.1126/science.306.5702.1673 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCouzin, Jennifer | |
| 245 | 0 | 0 |
_aClinical trials. Nail-biting time for trials of COX-2 drugs. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cDec 2004 |
||
| 300 |
_a1673-5 p. _bdigital |
||
| 500 | _aPublication Type: News | ||
| 650 | 0 | 4 |
_aAlzheimer Disease _xprevention & control |
| 650 | 0 | 4 |
_aAnticarcinogenic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 | _aCelecoxib |
| 650 | 0 | 4 | _aControlled Clinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntestinal Polyps _xprevention & control |
| 650 | 0 | 4 |
_aLactones _xadverse effects |
| 650 | 0 | 4 |
_aNeoplasms _xprevention & control |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPyrazoles |
| 650 | 0 | 4 |
_aSulfonamides _xadverse effects |
| 650 | 0 | 4 | _aSulfones |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 306 _gno. 5702 _gp. 1673-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.306.5702.1673 _zAvailable from publisher's website |
| 999 |
_c15261722 _d15261722 |
||